Stereotaxis, Inc.

NYSEAM:STXS Stock Report

Market Cap: US$174.0m

Stereotaxis Future Growth

Future criteria checks 2/6

Stereotaxis is forecast to grow earnings and revenue by 28.6% and 30.7% per annum respectively while EPS is expected to grow by 27.2% per annum.

Key information

28.6%

Earnings growth rate

27.18%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate30.7%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Jun 2026

Recent future growth updates

Recent updates

New Narrative • Jun 01

Manufacturing And Transition Risks Will Test Robotic Cardiology Platform Before Longer Term Potential Emerges

Catalysts About Stereotaxis Stereotaxis develops robotic systems, digital surgery platforms, and associated disposable devices for endovascular procedures in electrophysiology and other cardiovascular settings. What are the underlying business or industry changes driving this perspective?
New Narrative • May 18

Robotic And Digital Surgery Platforms Will Reshape Long Term Endovascular Procedure Potential

Catalysts About Stereotaxis Stereotaxis develops robotic and digital systems used in endovascular surgery, with a focus on electrophysiology and cardiovascular care. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Apr 03

Robotics And Digital Surgery Will Open New Frontiers

Strategic initiatives in robotics, digital surgery, and acquisitions might boost revenue, market size, and net margins through innovation and market expansion.

Earnings and Revenue Growth Forecasts

NYSEAM:STXS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202753-14N/AN/A4
12/31/202639-19N/AN/A4
3/31/202631-23-16-15N/A
12/31/202532-23-14-14N/A
9/30/202530-25-8-8N/A
6/30/202532-25-9-9N/A
3/31/202528-27-8-8N/A
12/31/202427-25-9-8N/A
9/30/202425-23-12-12N/A
6/30/202424-22-9-9N/A
3/31/202427-21-9-9N/A
12/31/202327-22-10-9N/A
9/30/202330-21-10-9N/A
6/30/202329-21-12-11N/A
3/31/202328-21-11-9N/A
12/31/202228-20-11-8N/A
9/30/202229-19-10-7N/A
6/30/202231-19-9-6N/A
3/31/202233-15-7-5N/A
12/31/202135-12-4-3N/A
9/30/202134-10-2-1N/A
6/30/202133-7-10N/A
3/31/202129-8-2-2N/A
12/31/202027-8-4-4N/A
9/30/202027-8-6-6N/A
6/30/202026-6-6-6N/A
3/31/202028-6-5-5N/A
12/31/201929-6N/A-5N/A
9/30/201929-6N/A-3N/A
6/30/201929-6N/A-3N/A
3/31/201929-4N/A-2N/A
12/31/201829-1N/A-3N/A
9/30/201830-3N/A-3N/A
6/30/201830-7N/A-3N/A
3/31/201831-7N/A-4N/A
12/31/201731-7N/A-5N/A
9/30/2017311N/A-4N/A
6/30/201731-7N/A-5N/A
3/31/201730-9N/A-5N/A
12/31/201632-12N/A-7N/A
9/30/201634-19N/A-5N/A
6/30/201635-7N/A-3N/A
3/31/201637-6N/A-3N/A
12/31/201538-7N/A-3N/A
9/30/201538-5N/A-6N/A
6/30/201538-4N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: STXS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: STXS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: STXS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: STXS's revenue (30.7% per year) is forecast to grow faster than the US market (11.8% per year).

High Growth Revenue: STXS's revenue (30.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if STXS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/07 23:48
End of Day Share Price 2026/06/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stereotaxis, Inc. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charley JonesBarrington Research Associates, Inc.
Neil ChatterjiB. Riley Securities, Inc.
Daniel StauderCitizens JMP Securities, LLC